| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
27.09 |
% |
10.6019/CHEMBL4513141 |
| Aspergillus niger |
Alpha-glucosidase |
IC50 |
57140.0 |
nM |
10.1016/j.bmcl.2017.10.025 |
| Bos taurus |
Beta-galactosidase |
IC50 |
200000.0 |
nM |
10.1021/acs.jmedchem.5b00951 |
| Bos taurus |
Beta-galactosidase |
Ki |
100000.0 |
nM |
10.1021/acs.jmedchem.5b00951 |
| Canavalia ensiformis |
Alpha-mannosidase |
IC50 |
75880.0 |
nM |
10.1016/j.bmcl.2017.10.025 |
| Canavalia ensiformis |
Alpha-mannosidase |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.5b00951 |
| Canavalia ensiformis |
Alpha-mannosidase |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.07.026 |
| Canavalia ensiformis |
Alpha-mannosidase |
Kd |
105130.0 |
nM |
10.1021/acs.jmedchem.1c00036 |
| Canavalia ensiformis |
Alpha-mannosidase |
Ki |
105130.0 |
nM |
10.1016/j.ejmech.2022.114621 |
| Candida albicans |
Candida albicans |
Inhibition |
2.16 |
% |
10.6019/CHEMBL4513141 |
| Coffea arabica |
Alpha-galactosidase |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.07.026 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
1.09 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Alpha-galactosidase |
Inhibition |
nan |
% |
10.1016/j.bmcl.2017.10.025 |
| Escherichia coli |
Beta-galactosidase |
EC50 |
40000.0 |
nM |
None |
| Escherichia coli |
Escherichia coli |
Inhibition |
5.82 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-glucocerebrosidase |
IC50 |
84000.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Ceramide glucosyltransferase |
IC50 |
1000000.0 |
nM |
10.1021/jm901281m |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
10.1016/j.bmcl.2017.08.035 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2017.08.035 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
CL |
0.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
1.7 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
1.7 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
1.7 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
1.7 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fa |
0.59 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.59 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.28 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Lactase-phlorizin hydrolase |
IC50 |
50000.0 |
nM |
10.1021/jm901281m |
| Homo sapiens |
Lysosomal alpha-glucosidase |
IC50 |
350.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Homo sapiens |
Lysosomal alpha-glucosidase |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Homo sapiens |
Lysosomal alpha-glucosidase |
IC50 |
2000.0 |
nM |
10.1021/jm901281m |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Inhibition |
nan |
% |
10.1021/jm301304e |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Potency |
2238.7 |
nM |
None |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Lysosomal alpha-mannosidase |
IC50 |
379000.0 |
nM |
10.1016/j.bmc.2014.09.034 |
| Homo sapiens |
Maltase-glucoamylase |
IC50 |
3700.0 |
nM |
10.1016/j.bmc.2016.06.013 |
| Homo sapiens |
Maltase-glucoamylase |
IC50 |
3700.0 |
nM |
10.1016/j.bmcl.2020.127751 |
| Homo sapiens |
Maltase-glucoamylase |
IC50 |
6000.0 |
nM |
10.1021/jm901281m |
| Homo sapiens |
Maltase-glucoamylase |
IC50 |
154300.0 |
nM |
10.1016/j.bmcl.2022.129069 |
| Homo sapiens |
Maltase-glucoamylase |
Ki |
1000.0 |
nM |
10.1016/j.bmc.2010.09.059 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
99.55 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
80.3 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Sucrase-isomaltase |
IC50 |
500.0 |
nM |
10.1021/jm901281m |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
IC50 |
40000.0 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
11.67 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
Mus musculus |
Activity |
27.3 |
% |
10.1021/acs.jmedchem.1c00036 |
| Mus musculus |
Mus musculus |
Activity |
36.6 |
% |
10.1021/acs.jmedchem.1c00036 |
| Mus musculus |
Mus musculus |
Activity |
40.4 |
% |
10.1021/acs.jmedchem.1c00036 |
| Mus musculus |
Mus musculus |
Activity |
40.5 |
% |
10.1021/jm301304e |
| Mus musculus |
Mus musculus |
Activity |
58.7 |
% |
10.1021/jm301304e |
| Mus musculus |
Mus musculus |
Activity |
233.28 |
mg/dl |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Activity |
273.6 |
mg/dl |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Activity |
287.55 |
mg/dl |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c00036 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm301304e |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm901281m |
| Mus musculus |
Mus musculus |
Inhibition |
21.96 |
% |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Inhibition |
23.06 |
% |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Inhibition |
27.31 |
% |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Inhibition |
30.02 |
% |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Inhibition |
39.23 |
% |
10.1016/j.ejmech.2022.114621 |
| Mus musculus |
Mus musculus |
Inhibition |
40.98 |
% |
10.1016/j.ejmech.2022.114621 |
| Oryctolagus cuniculus |
Glycogen debranching enzyme |
IC50 |
390.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
23.8 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Acidic alpha-glucosidase |
IC50 |
590.0 |
nM |
10.1016/j.bmcl.2010.11.112 |
| Rattus norvegicus |
Acidic alpha-glucosidase |
IC50 |
1300.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Rattus norvegicus |
Acidic alpha-glucosidase |
IC50 |
1300.0 |
nM |
10.1016/j.bmcl.2014.06.001 |
| Rattus norvegicus |
Acidic alpha-glucosidase |
IC50 |
1300.0 |
nM |
10.1021/jm301304e |
| Rattus norvegicus |
Acidic alpha-glucosidase |
Ki |
460.0 |
nM |
10.1021/jm301304e |
| Rattus norvegicus |
Lactase-glycosylceramidase |
Inhibition |
50.0 |
% |
10.1016/j.bmcl.2010.11.112 |
| Rattus norvegicus |
Plasma |
Fu |
1.0 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
110.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
430.0 |
nM |
10.1016/j.bmc.2016.06.013 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
1000.0 |
nM |
10.1016/j.bmcl.2010.11.112 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
1000.0 |
nM |
10.1016/j.bmcl.2014.06.001 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
1000.0 |
nM |
10.1021/jm301304e |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
1200.0 |
nM |
10.1016/j.bmc.2008.06.026 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
4600.0 |
nM |
10.1016/j.bmc.2016.06.013 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
39000.0 |
nM |
10.1016/j.bmcl.2010.11.112 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
39000.0 |
nM |
10.1016/j.bmcl.2014.06.001 |
| Rattus norvegicus |
Sucrase-isomaltase |
IC50 |
39000.0 |
nM |
10.1021/jm301304e |
| Saccharomyces cerevisiae |
Alpha-glucosidase MAL62 |
Inhibition |
50.0 |
% |
10.1021/np010360f |
| Saccharomyces cerevisiae S288c |
Oligo-1,6-glucosidase |
IC50 |
9900000.0 |
nM |
10.1016/j.bmcl.2009.08.012 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
9.83 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2289 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.15 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.0664 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
16.69 |
% |
10.6019/CHEMBL4513141 |
| Sus scrofa |
Uncharacterized protein |
IC50 |
700000.0 |
nM |
10.1021/np010360f |
| None |
ADMET |
CL |
1.7 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
2.7 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
2.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.28 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Fu |
1.0 |
None |
10.1124/dmd.108.020479 |
| None |
Unchecked |
Ac50 |
1.585 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.995 |
uM |
None |
| None |
Unchecked |
Ac50 |
14.13 |
uM |
None |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
Ac50 |
31.62 |
uM |
None |
| None |
Unchecked |
AC50 |
1584.9 |
nM |
None |
| None |
Unchecked |
AC50 |
1995.3 |
nM |
None |
| None |
Unchecked |
AC50 |
14130.0 |
nM |
None |
| None |
Unchecked |
AC50 |
17782.8 |
nM |
None |
| None |
Unchecked |
AC50 |
31622.8 |
nM |
None |
| None |
Unchecked |
IC50 |
50.0 |
nM |
10.1016/j.bmc.2017.07.026 |
| None |
Unchecked |
IC50 |
59.76 |
ug.mL-1 |
10.1016/j.bmc.2019.115148 |
| None |
Unchecked |
IC50 |
99.0 |
nM |
10.1016/j.bmc.2016.11.053 |
| None |
Unchecked |
IC50 |
100.0 |
nM |
10.1021/acs.jmedchem.5b00951 |
| None |
Unchecked |
IC50 |
590.0 |
nM |
10.1016/j.bmc.2016.11.053 |
| None |
Unchecked |
IC50 |
1300.0 |
nM |
10.1021/jm301304e |
| None |
Unchecked |
IC50 |
2430.0 |
nM |
10.1016/j.bmcl.2017.08.035 |
| None |
Unchecked |
IC50 |
8200.0 |
nM |
10.1016/j.bmc.2016.06.013 |
| None |
Unchecked |
IC50 |
164000.0 |
nM |
10.1016/j.bmc.2016.11.053 |
| None |
Unchecked |
IC50 |
171000.0 |
nM |
10.1016/j.bmc.2014.09.034 |
| None |
Unchecked |
IC50 |
200000.0 |
nM |
10.1021/jm901281m |
| None |
Unchecked |
IC50 |
201360.0 |
nM |
10.1016/j.bmcl.2017.10.025 |
| None |
Unchecked |
IC50 |
342000.0 |
nM |
10.1021/acs.jmedchem.5b00951 |
| None |
Unchecked |
IC50 |
378000.0 |
nM |
10.1016/j.bmc.2016.11.053 |
| None |
Unchecked |
IC50 |
462200.0 |
nM |
10.1016/j.bmcl.2017.04.078 |
| None |
Unchecked |
IC50 |
462200.0 |
nM |
10.1016/j.ejmech.2018.02.072 |
| None |
Unchecked |
IC50 |
462200.0 |
nM |
10.1039/C7MD00162B |
| None |
Unchecked |
IC50 |
1850000.0 |
nM |
10.1016/j.bmc.2014.09.034 |
| None |
Unchecked |
Inhibition |
50.0 |
% |
10.1016/j.bmc.2008.06.026 |
| None |
Unchecked |
Inhibition |
50.0 |
% |
10.1016/j.bmcl.2010.11.112 |
| None |
Unchecked |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.5b00951 |
| None |
Unchecked |
Inhibition |
50.0 |
% |
10.1021/np010360f |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.07.026 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2022.114621 |
| None |
Unchecked |
Kd |
20640.0 |
nM |
10.1021/acs.jmedchem.1c00036 |
| None |
Unchecked |
Kd |
nan |
None |
10.1021/acs.jmedchem.1c00036 |
| None |
Unchecked |
Ki |
28.0 |
nM |
10.1016/j.bmc.2017.07.026 |
| None |
Unchecked |
Ki |
60.0 |
nM |
10.1021/acs.jmedchem.5b00951 |
| None |
Unchecked |
Ki |
130.0 |
nM |
10.1016/j.bmc.2011.05.033 |
| None |
Unchecked |
Ki |
148.0 |
nM |
10.1016/j.bmc.2011.05.033 |
| None |
Unchecked |
Ki |
180.0 |
nM |
10.1016/j.ejmech.2022.114621 |
| None |
Unchecked |
Ki |
211.0 |
nM |
10.1016/j.bmc.2011.05.033 |
| None |
Unchecked |
Ki |
230.0 |
nM |
10.1016/j.bmc.2011.05.033 |
| None |
Unchecked |
Ki |
1000.0 |
nM |
10.1016/j.bmc.2011.05.033 |
| None |
Unchecked |
Ki |
20840.0 |
nM |
10.1016/j.ejmech.2022.114621 |
| None |
Unchecked |
Ki |
32000.0 |
nM |
10.1021/acs.jmedchem.5b00951 |
| None |
Unchecked |
Ratio Ki |
4.0 |
None |
10.1016/j.bmc.2011.05.033 |